Elodie Feurer

563 total citations
7 papers, 80 citations indexed

About

Elodie Feurer is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Elodie Feurer has authored 7 papers receiving a total of 80 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Physiology and 2 papers in Oncology. Recurrent topics in Elodie Feurer's work include Bone health and treatments (2 papers), Sarcoidosis and Beryllium Toxicity Research (2 papers) and Bone Metabolism and Diseases (2 papers). Elodie Feurer is often cited by papers focused on Bone health and treatments (2 papers), Sarcoidosis and Beryllium Toxicity Research (2 papers) and Bone Metabolism and Diseases (2 papers). Elodie Feurer collaborates with scholars based in France and United States. Elodie Feurer's co-authors include Roland Chapurlat, Jean‐Baptiste Pialat, Cécile‐Audrey Durel, Cyrille B. Confavreux, E. Berthoux, Elisabeth Sornay‐Rendu, Casina W.S. Kan, Martine Croset, P. Bielefeld and P. Sève and has published in prestigious journals such as Journal of Bone and Mineral Research, Annals of the Rheumatic Diseases and Bone.

In The Last Decade

Elodie Feurer

6 papers receiving 79 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elodie Feurer France 5 27 24 20 17 16 7 80
Yiqun Yang China 5 33 1.2× 9 0.4× 18 0.9× 9 0.5× 10 0.6× 21 95
Samantha Rodríguez‐Muguruza Spain 6 38 1.4× 5 0.2× 51 2.5× 17 1.0× 5 0.3× 23 89
François Bacot Canada 4 29 1.1× 18 0.8× 9 0.5× 5 0.3× 11 0.7× 5 88
Erna V. Ivarsdottir Iceland 4 21 0.8× 8 0.3× 35 1.8× 11 0.6× 1 0.1× 4 90
A. Arias Spain 6 29 1.1× 6 0.3× 9 0.5× 5 0.3× 8 0.5× 13 86
Hesham Hamoud Egypt 7 35 1.3× 4 0.2× 25 1.3× 28 1.6× 7 0.4× 19 124
Laurence Olivier-Faivre France 3 10 0.4× 21 0.9× 20 1.0× 9 0.5× 12 0.8× 6 73
Harumi Shirai Japan 4 30 1.1× 9 0.4× 21 1.1× 2 0.1× 16 1.0× 9 77
Precious Pearl Landburg Netherlands 5 35 1.3× 39 1.6× 7 0.3× 3 0.2× 15 0.9× 8 149
D. Denarié France 7 36 1.3× 18 0.8× 55 2.8× 4 0.2× 3 0.2× 13 124

Countries citing papers authored by Elodie Feurer

Since Specialization
Citations

This map shows the geographic impact of Elodie Feurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elodie Feurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elodie Feurer more than expected).

Fields of papers citing papers by Elodie Feurer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elodie Feurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elodie Feurer. The network helps show where Elodie Feurer may publish in the future.

Co-authorship network of co-authors of Elodie Feurer

This figure shows the co-authorship network connecting the top 25 collaborators of Elodie Feurer. A scholar is included among the top collaborators of Elodie Feurer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elodie Feurer. Elodie Feurer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Merle, Blandine, et al.. (2025). A Qualitative Approach to Quality of Life in Fibrous Bone Dysplasia /McCune Albright Syndrome: Looking Beyond Quantitative Analysis. Calcified Tissue International. 116(1). 18–18. 2 indexed citations
2.
Fontana, Ariel, et al.. (2024). AB1331 THE CARBON FOOTPRINT OF ADALIMUMAB BIOSIMILARS THROUGH THEIR LIFE CYCLE. Annals of the Rheumatic Diseases. 83. 2015–2016.
3.
Feurer, Elodie, et al.. (2020). A new LRP6 variant and Camurati-Engelmann-like disease. Bone. 143. 115706–115706. 4 indexed citations
4.
Feurer, Elodie, Casina W.S. Kan, Martine Croset, Elisabeth Sornay‐Rendu, & Roland Chapurlat. (2019). Lack of Association Between Select Circulating miRNAs and Bone Mass, Turnover, and Fractures: Data From the OFELY Cohort. Journal of Bone and Mineral Research. 34(6). 1074–1085. 21 indexed citations
5.
Feurer, Elodie, P. Bielefeld, David Saadoun, & P. Sève. (2014). Uvéites et biothérapies. La Revue de Médecine Interne. 36(2). 107–116. 6 indexed citations
6.
Feurer, Elodie & Roland Chapurlat. (2014). Emerging drugs for osteoporosis. Expert Opinion on Emerging Drugs. 19(3). 385–395. 14 indexed citations
7.
Durel, Cécile‐Audrey, Elodie Feurer, Jean‐Baptiste Pialat, et al.. (2013). Etanercept may induce neurosarcoidosis in a patient treated for rheumatoid arthritis. BMC Neurology. 13(1). 212–212. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026